Compare BKE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKE | BHC |
|---|---|---|
| Founded | 1948 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 1996 | 1996 |
| Metric | BKE | BHC |
|---|---|---|
| Price | $46.43 | $8.13 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 342.7K | ★ 3.3M |
| Earning Date | 11-20-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | 6.43 | ★ 423.08 |
| EPS | ★ 1.79 | N/A |
| Revenue | $1,297,835,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $5.47 | $6.81 |
| Revenue Next Year | $3.97 | N/A |
| P/E Ratio | $26.47 | ★ N/A |
| Revenue Growth | ★ 6.58 | N/A |
| 52 Week Low | $39.44 | $4.33 |
| 52 Week High | $58.52 | $9.04 |
| Indicator | BKE | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.50 | 69.25 |
| Support Level | $46.80 | $5.49 |
| Resistance Level | $47.53 | N/A |
| Average True Range (ATR) | 1.12 | 0.39 |
| MACD | -0.01 | 0.21 |
| Stochastic Oscillator | 69.05 | 67.61 |
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.